| AIM | Absence in melanoma 2 |
| ALRs | Absence in melanoma 2-like receptors |
| AP | Acute pancreatitis |
| ASC | Caspase recruitment domain |
| CAPS | Cryopyrin-associated periodic syndrome |
| CARD | Caspase activation and recruitment domain |
| CARS | Compensatory anti-inflammatory response syndrome |
| CLRs | C-type lectin receptors |
| COX-2 | Cyclo-oxygenase-2 |
| DAMPs | Damage-Associated Molecular Patterns |
| GSDM-D | Gasdermin-D |
| HMGB1 | High mobility group box 1 |
| IL | Interleukin |
| IL1R | Interleukin 1 receptor |
| IRAK | IL1R-associated kinase |
| IRF | Interferon regulatory factor |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MyD88 | Myeloid differentiation primary response 88 |
| NATCH | Nucleotide-binding and oligomerization domain |
| NF-κB | Nuclear factor-kappa B |
| NLRP3 | NLR pyrin domain containing protein 3 |
| NOD1 | NLR nucleotide-binding oligomerization domain-containing protein 1 |
| Nrf2 | Nuclear factor erythrocyte-2 associated factor 2 |
| NSAIDS | Non-steroidal anti-inflammatory drugs |
| PAMPs | Pathogen-Associated Molecular Patterns |
| PRR | Pattern recognition receptors |
| PYD | Pyrin domain |
| RAGE | Receptor for advanced glycation end-products |
| RLRs | Retinoic acid-inducible gene (RIG)-I-like receptors |
| ROS | Reactive oxygen species |
| SIRS | Systemic inflammatory response syndrome |
| TLR | Toll-like receptor |
| TNFα | Tumor necrosis factor alpha |
| TRAF | Tumor necrosis factor receptor-activated factor |
| TRIF | TIR-domain-containing adaptor molecule inducing interferon-beta |